v3.26.3
SCHEDULE OF AMOUNTS RECEIVABLE AND PREPAID EXPENSES (Details) (Parenthetical) - USD ($)
Jul. 31, 2026
Jul. 31, 2025
Receivables [Abstract]    
Prepaid expense [1] $ 813,987 $ 1,394,439
Prepaid expense non current $ 315,703 $ 717,508
[1] Prepaid expenses as of July 31, 2026 include amounts paid to certain vendors in respect of the Company’s ongoing pivotal phase III trial study. These amounts are amortized on a straight-line basis over the period of the clinical trial. Prepaid expenses estimated to be expensed within 12 months amount to $813,987 in 2026 compared to $1,394,439 in 2025 and are included in current assets, whilst the balance, extending longer than 12 months, amounts to $315,703 in 2026 as compared to $717,508 in 2025 and is included in non-current assets under long-term prepaid expenses.